Weifeng Mao

1.4k total citations
42 papers, 937 citations indexed

About

Weifeng Mao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Weifeng Mao has authored 42 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Weifeng Mao's work include DNA Repair Mechanisms (8 papers), Glioma Diagnosis and Treatment (4 papers) and Cell death mechanisms and regulation (4 papers). Weifeng Mao is often cited by papers focused on DNA Repair Mechanisms (8 papers), Glioma Diagnosis and Treatment (4 papers) and Cell death mechanisms and regulation (4 papers). Weifeng Mao collaborates with scholars based in China, United States and France. Weifeng Mao's co-authors include Jintao Lin, Tao Song, Cong Li, Yuwan Zhao, Jian Lv, Zhiwei Zhang, Zinan Zhao, Jianbing Qin, Guohua Jin and Meiling Tian and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and PLoS ONE.

In The Last Decade

Weifeng Mao

39 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weifeng Mao China 18 512 176 154 130 93 42 937
Cheol Hwangbo South Korea 19 648 1.3× 114 0.6× 163 1.1× 122 0.9× 137 1.5× 48 1.1k
Young‐Chae Chang South Korea 16 527 1.0× 117 0.7× 159 1.0× 146 1.1× 107 1.2× 29 1.1k
Ming‐Cheng Chen Taiwan 16 480 0.9× 201 1.1× 144 0.9× 67 0.5× 83 0.9× 50 936
Fangfang Liu China 19 381 0.7× 167 0.9× 115 0.7× 95 0.7× 70 0.8× 46 893
Galina Chipitsyna United States 20 516 1.0× 225 1.3× 149 1.0× 78 0.6× 83 0.9× 39 1.3k
Xu Zheng China 19 516 1.0× 166 0.9× 99 0.6× 156 1.2× 97 1.0× 50 924
Sin‐Aye Park South Korea 20 719 1.4× 208 1.2× 229 1.5× 89 0.7× 161 1.7× 44 1.1k
Jicheng Yue China 8 537 1.0× 81 0.5× 158 1.0× 69 0.5× 110 1.2× 15 1.0k
Weiwei Tao China 20 555 1.1× 136 0.8× 144 0.9× 52 0.4× 179 1.9× 37 1.1k
Zhong‐Fei Shen China 5 733 1.4× 241 1.4× 237 1.5× 83 0.6× 123 1.3× 9 1.2k

Countries citing papers authored by Weifeng Mao

Since Specialization
Citations

This map shows the geographic impact of Weifeng Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifeng Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifeng Mao more than expected).

Fields of papers citing papers by Weifeng Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weifeng Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifeng Mao. The network helps show where Weifeng Mao may publish in the future.

Co-authorship network of co-authors of Weifeng Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Weifeng Mao. A scholar is included among the top collaborators of Weifeng Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weifeng Mao. Weifeng Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Shuailong, et al.. (2024). Transcriptomic data of BT549 triple negative breast cancer cells treated with 20 µM NU7441, a DNA-dependent kinase inhibitor. Data in Brief. 53. 110183–110183. 8 indexed citations
3.
Luo, Can, Jin Deng, Liangkai Chen, et al.. (2022). Phthalate acid esters and polycyclic aromatic hydrocarbons concentrations with their determining factors among Chinese pregnant women: A focus on dietary patterns. The Science of The Total Environment. 852. 158344–158344. 22 indexed citations
4.
Gao, Xingjie, Yanqin Yang, Jia Wang, et al.. (2020). Inhibition of mitochondria NADH–Ubiquinone oxidoreductase (complex I) sensitizes the radioresistant glioma U87MG cells to radiation. Biomedicine & Pharmacotherapy. 129. 110460–110460. 13 indexed citations
5.
Wang, Di, Xia Zhang, Yajie Gao, et al.. (2020). <p>Research Progress and Existing Problems for Abscopal Effect</p>. Cancer Management and Research. Volume 12. 6695–6706. 10 indexed citations
6.
Mao, Weifeng, Xin Yi, Jianbing Qin, Meiling Tian, & Guohua Jin. (2019). CXCL12 promotes proliferation of radial glia like cells after traumatic brain injury in rats. Cytokine. 125. 154771–154771. 13 indexed citations
7.
8.
Zhao, Qian, Yuanhua Qin, Peng Ren, et al.. (2017). Curcumin sensitizes lymphoma cells to DNA damage agents through regulating Rad51-dependent homologous recombination. Biomedicine & Pharmacotherapy. 97. 115–119. 28 indexed citations
9.
Zhao, Qian, Zhiwei Zhang, Jian Lv, et al.. (2017). Inhibition of Rad51 sensitizes breast cancer cells with wild-type PTEN to olaparib. Biomedicine & Pharmacotherapy. 94. 165–168. 24 indexed citations
10.
Zhao, Yuwan, Jian Lv, Zhiwei Zhang, et al.. (2017). Berberine activates caspase-9/cytochrome c-mediated apoptosis to suppress triple-negative breast cancer cells in vitro and in vivo. Biomedicine & Pharmacotherapy. 95. 18–24. 103 indexed citations
11.
Zhao, Qian, et al.. (2016). Nuclear PTEN interferes with binding of Ku70 at double-strand breaks through post-translational poly(ADP-ribosyl)ation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1863(12). 3106–3115. 10 indexed citations
12.
Mao, Weifeng, Xin Yi, Jianbing Qin, Meiling Tian, & Guohua Jin. (2016). CXCL12/CXCR4 Axis Improves Migration of Neuroblasts Along Corpus Callosum by Stimulating MMP-2 Secretion After Traumatic Brain Injury in Rats. Neurochemical Research. 41(6). 1315–1322. 19 indexed citations
13.
Li, Lei, Nan Xu, Ning Fan, et al.. (2015). Upregulated KLK10 inhibits esophageal cancer proliferation and enhances cisplatin sensitivity in vitro. Oncology Reports. 34(5). 2325–2332. 11 indexed citations
14.
15.
Qin, Yuanhua, et al.. (2013). Anisakiasis in China: The First Clinical Case Report. Foodborne Pathogens and Disease. 10(5). 472–474. 20 indexed citations
16.
Mao, Weifeng, Xin Yi, Jianbing Qin, Meiling Tian, & Guohua Jin. (2013). CXCL12 inhibits cortical neuron apoptosis by increasing the ratio of Bcl-2/Bax after traumatic brain injury. International Journal of Neuroscience. 124(4). 281–290. 34 indexed citations
17.
Mao, Weifeng, Taejoong Kim, & Hans H. Cheng. (2013). Visualization of Marek’s disease virus in vitro using enhanced green fluorescent protein fused with US10. Virus Genes. 47(1). 181–183. 4 indexed citations
18.
Mao, Weifeng, Minhua Shao, Ji Ma, et al.. (2012). The important roles of RET, VEGFR2 and the RAF/MEK/ERK pathway in cancer treatment with sorafenib. Acta Pharmacologica Sinica. 33(10). 1311–1318. 38 indexed citations
19.
Cheng, Hans H., Masahiro Niikura, Weifeng Mao, et al.. (2008). Using Integrative Genomics to Elucidate Genetic Resistance to Marek’s Disease in Chickens. PubMed. 132. 365–372. 12 indexed citations
20.
Mao, Weifeng, Masahiro Niikura, Robert F. Silva, & Hans H. Cheng. (2007). Quantitative evaluation of viral fitness due to a single nucleotide polymorphism in the Marek's disease virus UL41 gene via an in vitro competition assay. Journal of Virological Methods. 148(1-2). 125–131. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cheol Hwangbo Breakdown of academic impact, for papers by Young‐Chae Chang Breakdown of academic impact, for papers by Ming‐Cheng Chen Breakdown of academic impact, for papers by Fangfang Liu Breakdown of academic impact, for papers by Galina Chipitsyna Breakdown of academic impact, for papers by Xu Zheng Breakdown of academic impact, for papers by Sin‐Aye Park Breakdown of academic impact, for papers by Jicheng Yue Breakdown of academic impact, for papers by Weiwei Tao Breakdown of academic impact, for papers by Zhong‐Fei Shen
Rankless by CCL
2026